Tetra Discovery Partners LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tetra Discovery Partners LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11185
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tetra Discovery Partners LLC (Tetra Discovery) is a drug development company that researches and develops pharmaceutical drugs based on phosphodiesterase (PDE) sub-type inhibitors for neuroscience and non-neuroscience disorders. The company uses structure-guided drug design chemistry approach to discover allosteric inhibitors of phosphodiesterase 4 subtypes such as PDE4B and PDE4D. Its PDE4B drug is developed for treating various neuroinflammation and traumatic brain injury. Tetra Discovery also offers drugs for the treatment of depression and schizophrenia, Alzheimer’s disease, other dementias, traumatic brain injury, psychiatric diseases, and neurodevelopmental disorders. The company partners with various universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system. Tetra Discovery is headquartered in Grand Rapids, Michigan, the US.

Tetra Discovery Partners LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Tetra Discovery Partners Raises USD6 Million in Venture Financing 10
Tetra Discovery Partners Raises USD5 Million in Series A Venture Financing 11
Tetra Discovery Partners Raises USD4.3 Million in Venture Financing 12
Tetra Discovery Raises USD1 Million in Venture Financing 13
Tetra Discovery Raises Funds through Venture Financing 14
Tetra Discovery Raises USD0.3 Million in Venture Financing 15
Tetra Discovery Raises US$1 Million In Seed Financing 16
Partnerships 17
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 17
Tetra Discovery Partners LLC – Key Competitors 18
Tetra Discovery Partners LLC – Key Employees 19
Tetra Discovery Partners LLC – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jan 17, 2017: Tetra Discovery Partners appoints vice president of clinical operations 21
Product News 22
01/17/2017: Tetra Discovery Partners Appoints Richard Erwin as Vice President, Clinical Operations 22
Product Approvals 23
Apr 03, 2018: FDA Grants Orphan Drug Designation for Tetra Discovery Partners BPN14770 for the Treatment of Fragile X Syndrome 23
Clinical Trials 24
Mar 15, 2018: Tetra Discovery Partners Announces FDA Clearance of IND for Phase 2 Trial of BPN14770 in Fragile X Syndrome 24
Nov 07, 2017: New Preclinical Research Suggests Utility of Tetra Discovery Partners’ BPN14770 to Provide Therapeutic Benefit in Fragile X Syndrome 25
Nov 06, 2017: Tetra Discovery Partners Research Supports Ability of Novel Selective PDE4D Inhibitor, BPN14770, to Improve Memory and Cognition 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Key Facts 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetra Discovery Partners LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tetra Discovery Partners Raises USD6 Million in Venture Financing 10
Tetra Discovery Partners Raises USD5 Million in Series A Venture Financing 11
Tetra Discovery Partners Raises USD4.3 Million in Venture Financing 12
Tetra Discovery Raises USD1 Million in Venture Financing 13
Tetra Discovery Raises Funds through Venture Financing 14
Tetra Discovery Raises USD0.3 Million in Venture Financing 15
Tetra Discovery Raises US$1 Million In Seed Financing 16
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 17
Tetra Discovery Partners LLC, Key Competitors 18
Tetra Discovery Partners LLC, Key Employees 19

List of Figures
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetra Discovery Partners LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tetra Discovery Partners LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IntraPace Inc-医療機器分野:企業M&A・提携分析
    Summary IntraPace Inc (IntraPace) is a medical device company that develops novel implantable systems. The company provides abiliti systems that contains sensors intended to track consumption events and physical activity using this information to direct when therapy is delivered and to monitor a pat …
  • ICU Medical Inc (ICUI)-医療機器分野:企業M&A・提携分析
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • North Carolina Biotechnology Center-製薬・医療分野:企業M&A・提携分析
    Summary North Carolina Biotechnology Center (NCBiotech) is a life-science service provider that offers economic development services. The organization provides hamner conference center, office space for rent, and biotech business library services. It offers meeting space, catering, rooms and service …
  • The Home Depot, Inc.:企業の戦略・SWOT・財務情報
    The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Andrew Peller Limited:企業の戦略・SWOT・財務分析
    Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report Summary Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Minesto AB (MINEST):電力:M&Aディール及び事業提携情報
    Summary Minesto AB (Minesto) is a marine energy technology developer. The company offers ervices such as renewable energy solutions, tidal power plants operations and management, power generation, and deep green technology solutions. It also provides control-system design, hydrodynamics, simulation, …
  • Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines for heart diseases using stem cell-derived, patient-specific cardiac disease models. It also devel …
  • Fletcher Building Ltd:企業のM&A・事業提携・投資動向
    Fletcher Building Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fletcher Building Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • J.Crew Group, Inc.:企業の戦略・SWOT・財務情報
    J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • Korea Gas Corp (036460):企業の財務・戦略的SWOT分析
    Korea Gas Corp (036460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Kimbell Royalty Partners LP (KRP):石油・ガス:M&Aディール及び事業提携情報
    Summary Kimbell Royalty Partners LP (KRP), is an oil and gas company that owns and acquires mineral and royalty interests in oil and natural gas properties throughout the US. The company has interests in the Permian Basin, Eagle Ford, Bakken Shale, San Juan Basin, Mid-Continent, East Texas, Barnett …
  • Bank of the Ryukyus, Ltd.:企業の戦略・SWOT・財務情報
    Bank of the Ryukyus, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of the Ryukyus, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Fidelity Bank Plc:企業の戦略・SWOT・財務情報
    Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • American Packaging Corporation:企業の戦略・SWOT・財務情報
    American Packaging Corporation - Strategy, SWOT and Corporate Finance Report Summary American Packaging Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Estel Technologies Pvt. Ltd:企業の戦略的SWOT分析
    Estel Technologies Pvt. Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Inscape Corporation:企業の戦略・SWOT・財務情報
    Inscape Corporation - Strategy, SWOT and Corporate Finance Report Summary Inscape Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Puma Biotechnology Inc (PBYI):企業の財務・戦略的SWOT分析
    Puma Biotechnology Inc (PBYI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cisco Systems, Inc (CSCO)-エネルギー分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Almac Group Ltd:企業のM&A・事業提携・投資動向
    Almac Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Almac Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆